skip to main content
DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Synthetic heparin-binding factor analogs

Abstract

The invention provides synthetic heparin-binding growth factor analogs having at least one peptide chain, and preferably two peptide chains branched from a dipeptide branch moiety composed of two trifunctional amino acid residues, which peptide chain or chains bind a heparin-binding growth factor receptor and are covalently bound to a non-signaling peptide that includes a heparin-binding domain, preferably by a linker, which may be a hydrophobic linker. The synthetic heparin-binding growth factor analogs are useful as pharmaceutical agents, soluble biologics or as surface coatings for medical devices.

Inventors:
 [1];  [2];  [3];  [4]
  1. Poquott, NY
  2. Gaithersburg, MD
  3. Plainview, NY
  4. Shoreham, NY
Issue Date:
Research Org.:
Brookhaven National Laboratory (BNL), Upton, NY (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
989000
Patent Number(s):
7,700,563
Application Number:
7,700,563
Assignee:
BioSurface Engineering Technologies, Inc. (Rockville, MD); Brookhaven Science Associates (Upton, NY) BNL
DOE Contract Number:  
AC02-98CH10886
Resource Type:
Patent
Country of Publication:
United States
Language:
English
Subject:
37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CHEMISTRY

Citation Formats

Pena, Louis A, Zamora, Paul O, Lin, Xinhua, and Glass, John D. Synthetic heparin-binding factor analogs. United States: N. p., 2010. Web.
Pena, Louis A, Zamora, Paul O, Lin, Xinhua, & Glass, John D. Synthetic heparin-binding factor analogs. United States.
Pena, Louis A, Zamora, Paul O, Lin, Xinhua, and Glass, John D. Tue . "Synthetic heparin-binding factor analogs". United States. https://www.osti.gov/servlets/purl/989000.
@article{osti_989000,
title = {Synthetic heparin-binding factor analogs},
author = {Pena, Louis A and Zamora, Paul O and Lin, Xinhua and Glass, John D},
abstractNote = {The invention provides synthetic heparin-binding growth factor analogs having at least one peptide chain, and preferably two peptide chains branched from a dipeptide branch moiety composed of two trifunctional amino acid residues, which peptide chain or chains bind a heparin-binding growth factor receptor and are covalently bound to a non-signaling peptide that includes a heparin-binding domain, preferably by a linker, which may be a hydrophobic linker. The synthetic heparin-binding growth factor analogs are useful as pharmaceutical agents, soluble biologics or as surface coatings for medical devices.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2010},
month = {4}
}

Patent:

Save / Share: